Comerica Bank Decreases Stock Position in Dolby Laboratories $DLB

Comerica Bank trimmed its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 25.1% during the fourth quarter, HoldingsChannel reports. The fund owned 34,618 shares of the electronics maker’s stock after selling 11,579 shares during the quarter. Comerica Bank’s holdings in Dolby Laboratories were worth $2,223,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. AQR Capital Management LLC boosted its holdings in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares during the period. First Trust Advisors LP grew its position in Dolby Laboratories by 22.7% in the 3rd quarter. First Trust Advisors LP now owns 1,518,657 shares of the electronics maker’s stock valued at $109,905,000 after buying an additional 281,214 shares in the last quarter. Vanguard Group Inc. increased its stake in Dolby Laboratories by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after buying an additional 203,411 shares during the period. State Street Corp increased its stake in Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Dolby Laboratories by 218.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after acquiring an additional 171,288 shares during the period. 58.56% of the stock is currently owned by institutional investors.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, CAO Ryan Nicholson sold 2,667 shares of the firm’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $66.38, for a total value of $177,035.46. Following the completion of the transaction, the chief accounting officer directly owned 36,956 shares in the company, valued at $2,453,139.28. This trade represents a 6.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the completion of the transaction, the senior vice president directly owned 83,218 shares in the company, valued at approximately $5,504,038.52. This trade represents a 3.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 37.93% of the company’s stock.

Dolby Laboratories Stock Performance

NYSE DLB opened at $59.16 on Wednesday. Dolby Laboratories has a 1 year low of $55.73 and a 1 year high of $78.28. The business’s fifty day moving average is $62.48 and its two-hundred day moving average is $64.42. The stock has a market capitalization of $5.65 billion, a P/E ratio of 23.38 and a beta of 0.86.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts forecast that Dolby Laboratories will post 3.17 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DLB. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Get Our Latest Stock Report on DLB

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Articles

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.